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Abstract. The effect of 20 trihaloacetylazulene derivatives
with one halogen atom, on nitric oxide (NO) production by
mouse macrophage-like cells Raw 264.7 was investigated. 2-
Methoxyazulenes and 2-ethoxyazulenes exhibited comparable
cytotoxicity. Trichloroacetylazulenes generally exhibited higher
cytotoxicity, as compared with the corresponding
trifluoroacetylazulenes. Substitution of chloride, bromide or
iodine at the C-3 position further enhanced their cytotoxicity.
All of these compounds failed to stimulate the Raw 264.7 cells
to produce detectable amounts of NO, but did inhibit NO
production by LPS-activated Raw 264.7 cells to different
extents. 1-Trichloroacetyl-2-methoxyazulene and 1-
trichloroacetyl-2-ethoxyazulene, with less cytotoxic activity,
inhibited NO production to the greatest extent, producing the
highest selectivity index (SI) of >24.7 and >28.7, respectively.
This was accompanied by the efficient inhibition of inducible
NO synthase (iNOS) mRNA expression, but not by iNOS
protein abundance. Electron spin resonance (ESR)
spectroscopy showed that neither of these compounds
produced radicals, nor scavenged NO, superoxide anion or
diphenyl-2-picrylhydrazyl radicals. The present study suggests
that the inhibitory effects of trifluoroacetylazulenes and
trichloroacetylazulenes on NO production by activated
macrophages might be derived from the perturbation of NO
anabolism (inhibition of iNOS mRNA expression and possibly
the inactivation of iNOS protein) rather than NO catabolism
(NO scavenging).
Azulene (1-4), an isomer of naphthalene, has a dipole
moment and a resonance energy having intermediate values
between that of benzene and naphthalene, and is
considerably more reactive, when compared with the two
arenes. Azulene derivatives have been investigated for their
synthesis and chemical reactions (5-7). They have been
shown to have several biological activities, including
antibacterial activity (8), anti-ulcer activity (9), relaxant
activity (10), inhibition of thromboxane A2-induced
vasoconstriction and thrombosis (11), acute toxicity and
local anesthetic activity (12), and chemotherapeutic activity
against mucous membrane diseases (13, 14). However, the
effects of azulene derivatives on cellular functions have not
yet been investigated in detail.
We initiated the structure–activity study of azulene,
tropolone and azulenequinone-related compounds (15-23).
Among 107 compounds so far analyzed, 2-acetylamino-
azulene, diethyl 2-chloroazulene-1,3-dicarboxylate, methyl 7-
isopropyl-2-methoxyazulene-1-carboxylate (16), tropolone
derivatives with a phenolic OH group, hinokithiol and its
tosylate and methyl ethers (18), 3-(3-guaiazulenyl)-1,5-
azulenequinone, 7-isopropyl-3-(4-methylanilino)-2-methyl-1,5-
azulenequinone (20), 2,3-dimethyl-1-trichloroacetylazulene
and 1,3-ditrichloroacetyl-4,6,8-trimethylazulene (22) showed
higher tumor-specific cytotoxic activity than other compounds.
1,3-Difluoroazulene (15), 2,4-dibromo-7-methoxytropone
(17), 3-morpholino-1,5-azulenequinone, 3,7-dibromo-1,5-
azulenequinone (19), 3-trifluoroacetylguaiazulene, 1-tri-
fluoroacetyl-4,6,8-trimethylazulene, 3-methyl-1-trichloro-
acetylazulene and 3-ethyl-1-trichloroacetylazulene (21)
inhibited nitric oxide (NO) production by lipopoly-
saccharide (LPS)-activated mouse macrophages, with (17,
19, 21) or without (15) the inhibition of inducible NO
synthase (iNOS) mRNA and protein expression. However,
the extent of inhibition of iNOS expression varied
considerably from compound to compound (17, 19, 21).
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We recently reported that 1-trichloroacetyl-3-bromo-2-
methoxyazulene and 1-trichloroacetyl-3-chloro-2-
ethoxyazulene (2d and 4c respectively) among twenty
trihaloacetylazulene derivatives with either one atom of
fluorine, chlorine, bromine or iodine (Figure 1) showed the
highest tumor specificity (23). These compounds induced
apoptotic cell death in HL-60 cells, whereas they induced
autophagic cell death characterized by autophagosome
formation in human squamous cell carcinoma HSC-4 cells,
suggesting the diversity of the type of cell death induced in
human tumor cell lines by trihaloacetylazulene derivatives
(23). Here, we investigated whether these twenty
trihaloacetylazulene derivatives inhibit NO production by
unstimulated- and LPS-stimulated mouse macrophage-like
Raw 264.7 cells, and if so, whether they affect the NO
anabolism (iNOS protein and mRNA expressions, assessed
by western blotting and RT-PCR analyses) and NO
catabolism (NO scavenging activity, assessed by electron
spin resonance (ESR) spectroscopy).
Materials and Methods
Materials. The following chemicals and reagents were obtained
from the companies indicated: Dulbecco's modified Eagle’s
medium (DMEM), phenol red-free DMEM (Gibco BRL, Grand
Island, NY, USA); fetal bovine serum (FBS) (JRH Bioscience,
Lenexa, KS, USA); 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT), dimethyl sulfoxide (DMSO) (Wako
Pure Chem. Ind., Ltd., Osaka, Japan); LPS from Escherichia coli
(Serotype 0111:B4), hypoxanthine (HX), xanthine oxidase (XOD),
diethylenetriaminepentaacetic acid (DETAPAC), diphenyl-2-
picrylhydrazyl (DPPH), phenylmethylsulfonyl fluoride (PMSF)
(Sigma Chem. Co., St. Louis, MO, USA); 5,5-dimethyl-
1-pyrroline-N-oxide (DMPO), 2-(4-carboxyphenyl)-4,4,5,5-tetra-
methylimidazoline-1-oxy-1-3-oxide (carboxy-PTIO; a spin trap
agent), 1-hydroxy-2-oxo-3-(N-3-methyl-3-aminopropyl)-3-methyl-
1-triazene (NOC-7; a NO generator) (Dojin, Kumamoto, Japan). 
Synthesis of trihaloacetylazulenes. Trihaloacetylazulene derivatives
were synthesized, according to methods previously published: 1-
trifluoroacetyl-2-methoxyazulene [1a] (24-27), 1-trifluoroacetyl-3-
fluoro-2-methoxyazulene [1b] (25, 28-30), 1-trifluoroacetyl-3-
chloro-2-methoxyazulene [1c] (25, 31-34), 1-trifluoroacetyl-3-
bromo-2-methoxyazulene [1d] (25, 31-34), 1-trifluoroacetyl-3-iodo-
2-methoxyazulene [1e] (25, 31, 32), 1-trichloroacetyl-2-
methoxyazulene [2a] (24-27), 1-trichloroacetyl-3-fluoro-2-
methoxyazulene [2b] (25, 28-30), 1-trichloroacetyl-3-chloro-2-
methoxyazulene [2c] (25, 31-34), 1-trichloroacetyl-3-bromo-2-
methoxyazulene [2d] (25, 31-34), 1-trichloroacetyl-3-iodo-2-
methoxyazulene [2e] (25, 31, 32), 1-trifluoroacetyl-2-ethoxyazulene
[3a] (24-27, 34), 1-trifluoroacetyl-2-ethoxy-3-fluoroazulene [3b] (25,
28-30), 1-trifluoroacetyl-3-chloro-2-ethoxyazulene [3c] (25, 31-34),
1-trifluoroacetyl-3-bromo-2-ethoxyazulene [3d] (25, 31-34), 
1-trifluoroacetyl-2-ethoxy-3-iodoazulene [3e] (25, 31, 32), 
1-trichloroacetyl-2-ethoxyazulene [4a] (24-27, 34), 1-trichloroacetyl-
2-ethoxy-3-fluoroazulene [4b] (25, 28-30), 1-trichloroacetyl-3-
chloro-2-ethoxyazulene [4c] (25, 31-34), 1-trichloroacetyl-3-bromo-
2-ethoxyazulene [4d] (25, 31-34), 1-trichloroacetyl-2-ethoxy-3-
iodoazulene [4e] (25, 31, 32) (Figure 1).
Cell culture. Mouse macrophage-like Raw 264.7 cells were cultured
in DMEM supplemented with 10% heat-inactivated FBS under a
humidified 5% CO2 atmosphere (15, 17, 19, 21).
Assay for cytotoxic activity. Cytotoxic activity of azulenes was
determined by the MTT method and expressed as absorbance at 540
nm of the MTT-stained cells. The 50% cytotoxic concentration
(CC50) was determined from the dose-response curve (15, 17, 19, 21).
Assay for NO concentration. Near confluent Raw 264.7 cells were
incubated for 24 hours with each test sample in phenol red-free
DMEM supplemented with 10% FBS in the presence or absence
of 100 ng/mL LPS, and the NO production by Raw 264.7 cells was
quantified by Greiss reagent, using a standard curve of NO2–. To
eliminate the interaction between sample and Greiss reagent, the
NO concentration in the culture medium without cells was
measured and was subtracted from the value obtained using the
cells. The concentration that inhibited the LPS-stimulated NO
production by 50% (50% inhibitory concentration: IC50) was
determined from the dose-response curve (15, 17, 19, 21). The
efficacy of inhibition of NO production was evaluated by the
selectivity index (SI), which was calculated using the following
equation: SI=CC50 / IC50.
Western blotting. The pelleted cells were lysed with 100 ÌL of lysis
buffer (10 mM Tris-HCl, pH 7.6, 1% Triton X-100, 150 mM NaCl,
5 mM EDTA and 2 mM PMSF) for 10 minutes in iced water, and
then incubated for 50 minutes at 4ÆC with RT-5 ROTATOR (Titec,
Saitama, Japan). The cell lysates were centrifuged at 16,000 xg for
ANTICANCER RESEARCH 28: 171-178 (2008)
172
Figure 1. Structure of ten trifluoroacetylazulenes (1a-e, 3a-e) and ten
trichloroacetylazulenes (2a-e, 4a-e).
20 minutes at 4ÆC to remove insoluble materials and the
supernatant was collected. The protein concentrations of
supernatant were measured by Protein Assay Kit (Bio Rad,
Hercules, CA, USA). An equal amount of the protein from cell
lysates (10 Ìg) was mixed with 2x sodium dodecyl sulfate (SDS)-
sample buffer (0.1 M Tris-HCl, pH 6.8, 20% glycerol, 4% SDS,
0.01% bromphenol blue, 1.2% 2-mercaptoethanol), boiled for 10
minutes, applied to the SDS-8% polyacrylamide gel
electrophoresis, and then transferred to polyvinylidene difluoride
(PVDF) membrane. The membranes were blocked with 5%
skimmed milk in phosphate-buffered saline (PBS(-)) plus 0.05%
Tween 20 for 90 minutes and incubated for 90 minutes at room
temperature with anti-iNOS antibody (1:1,000, Santa Cruz
Biotechnology, Delaware, CA, USA), or anti-actin antibody
(1:2000-4000, Sigma), and then incubated with horseradish
peroxidase-conjugated anti-mouse or goat IgG for 90 minutes at
room temperature. Immunoblots were developed with a Western
Lightningì Chemiluminescence Reagent Plus (Perkin Elmer Life
Sciences, Boston, MA, USA) and analyzed on a Macintosh (Power
Macintosh 7600/120) computer using the public domain NIH
Image program (National Technical Information Service,
Springfield, Virginia, USA, part number PB95-500195GEI). 
Assay for mRNA expression. Total RNA was isolated by
PURESCRIPT RNA Isolation kit (Gentra systems, Minneapolis, MN,
USA) protocol. Raw 264.7 cells were lysed in 300 ÌL cell lysis solution,
then 100 ÌL Protein-DNA precipitation solution were added. Cell
lysates were centrifuged at 15,000 xg for 3 minutes. To the
supernatant, 300 ÌL isopropanol was added. After centrifugation at
15,000 xg for 3 minutes, the pellet was washed in 300 mL 75% ethanol.
After centrifugation at 15,000 xg for 1 minute, the pellet was air dried
for 15 minutes and dissolved in DEPC-treated H2O. A reverse
transcriptase reaction (RT) was performed with 1.0 Ìg of total RNA,
using the Rever Tra Ace (Toyobo Co., LTD, Japan) with oligo (dT)20
primer (15, 17, 19, 21). Single-strand cDNA obtained by the RT
reaction was amplified using the KOD plus (Toyobo Co.) with iNOS
specific primers (5’-CCCTTCCGAAGTTTCTGGCAGCAGC-3’ and
5’-GGCTGTCAGAGCCTCGTGGCTTTGG-3’) and ‚-actin specific
primers (5'-GAGGCCCAGAGCAAGAGAGG-3' and 5'-TACAT
GGCTGGGGTGTTGAA-3'), according to the manufacturer’s
protocol. The RT-PCR products were applied to 2% agarose gel and
the ethidium bromide-stained gel was then photographed under UV
light and analyzed as described above. 
Radical scavenging activity. The radical intensity of trihaloacetyl-
azulenes was determined at 25ÆC, using ESR spectroscopy (JEOL
JES REIX Tokyo, Japan, X-band, 100 kHz modulation frequency)
(15, 17, 19, 21). Samples (24 mM dissolved in DMSO) were mixed
with an equal volume of 0.2 M KOH (pH 13.5). The radical intensity
was measured 40 seconds thereafter (center field, 336.0±5.0 mT;
microwave power, 16 mW; modulation amplitude, 0.1 mT; gain, 630
mW; time constant, 0.03 s; scanning time, 2 minutes). 
The radical intensity of NO, produced from the reaction mixture
of 20 ÌM carboxy-PTIO and 60 ÌM NOC-7, was determined in 0.1 M
phosphate buffer, pH 7.4 in the presence of 30% DMSO
(microwave power and gain were changed to 5 mW and 400 mW,
respectively). When NOC-7 (NO generator) and carboxy-PTIO
(spin trapping agent) were mixed, NO was oxidized to NO2 and
carboxy-PTIO was reduced to carboxy-PTI, which produces seven-
line signals. Samples were added 3 minutes after mixing. The NO
radical intensity was defined as the ratio of signal intensity of the
first peak of carboxy-PTI to that of MnO (15, 17, 19, 21) and
expressed as the ratio to the height of MnO, an external marker. 
For determination of superoxide anion (O2–) produced by HX
and XOD reactions (total volume: 200 ÌL) [50 ÌL of 2 mM HX
in 0.1 M phosphate buffer (pH 7.4) (PB)], 20 ÌL of 0.5 mM
DETAPAC, 30 ÌL of 8% DMPO, 40 ÌL of sample in DMSO, 30
ÌL of H2O or SOD, 30 ÌL of XOD (0.5 U/mL in PB) were used
and the gain was changed to 400. The O2– scavenging activity was
expressed as the ratio of the intensity of the first peak of DMPO-
OOH to that of MnO.
For determination of DPPH radical scavenging activity, samples
were mixed with the reaction mixture (total volume: 120 ÌL) (60 ÌL
of 100 ÌM DPPH, 60 ÌL of sample in DMSO), and 1 minute
thereafter subjected to ESR spectroscopy (35). Microwave power
and gain were changed to 8 mW and 500 mW, respectively.
Statistics. Student’s t-test was used to assess the statistical
significance between the two groups.
Results
Structure and activity relationship. There was no apparent
difference in the cytotoxic activity between 2-methoxyazulenes
(1a-e, 2a-e) and 2-ethoxyazulenes (3a-e, 4a-e) (Table I).
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Table I. Cytotoxicity of trihaloacetylazulenes and their effect on NO
production by LPS-stimulated Raw 264.7 cells.
Compound MW. CC50 (ÌM) IC50 (ÌM) SI
(–)LPS (+)LPS (+)LPS
1a 254.2 >500.0 >500.0 219.1 >2.6
1b 272.2 >500.0 >500.0 238.1 >2.4
1c 288.7 >117.0 >109.9 32.3 >9.7
1d 333.1 178.3 124.0 52.9 2.4
1e 380.1 174.2 86.5 28.2 8.4
2a 303.6 >393.6 >400.6 22.7 >24.7
2b 321.6 248.7 157.4 36.8 6.4
2c 338.0 112.7 96.5 30.9 5.7
2d 382.5 46.5 74.2 20.8 5.4
2e 429.5 130.9 124.7 17.6 8.6
3a 268.3 >500.0 >500.0 247.7 >2.5
3b 286.2 >500.0 >341.6 199.2 >1.4
3c 302.7 169.7 119.5 61.6 1.9
3d 347.1 >166.7 >152.8 43.0 >4.2
3e 394.1 >166.7 >125.0 74.3 >1.7
4a 317.6 358.8 >500.0 21.2 >28.7
4b 335.6 >365.6 >258.0 20.6 >12.5
4c 352.0 106.7 66.1 16.5 4.9
4d 396.5 66.1 63.8 13.3 4.7
4e 443.5 >98.1 77.7 10.6 7.6
SI: Selectivity index (CC50/IC50). Each value represents the mean from
3~6 independent experiments. Raw 264.7 cells were incubated for 24
hours with various concentrations of each compound (2-500 ÌM) in the
presence (+) or absence (–) of 100 ng/mL LSP. The CC50 and IC50
values were determined by the dose–response curve.
Trichloroacetylazulenes (2a-e, 4a-e) generally exhibited higher
cytotoxicity as compared with their corresponding trifluoro-
acetylazulenes (1a-e, 3a-e). In particular, trifluoroacetylazulenes
(1a, 1b, 3a, 3b) showed low cytotoxic activity whereas 
1-trichloroacetyl-3-bromo-2-methoxyazulene (2d) and 
1-trichloroacetyl-3-bromo-2-ethoxyazulene (4d) showed the
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Figure 2. Effect of trihaloacetylazulenes on the NO production by LPS-stimulated Raw 264.7 cells. Near-confluent Raw 264.7 cells were incubated for
24 hours with the indicated concentrations of (A) 1-trichloroacetyl-2-methoxyazulene (2a) or (B) 1-trichloroacetyl-2-ethoxyazulene (4a) in the absence
(open symbols) or presence (closed symbols) of 100 ng/mL LPS in phenol red-free DMEM supplemented with 10% FBS. The viable cell number
(expressed as % of control) (●, ●) and extracellular concentration of NO (■, ■) were determined by MTT assay and Griess reagent, respectively. Each
value represents the mean from 3 independent experiments.
highest cytotoxicity (Table I). Substitution of chloride (1c, 2c,
3c, 4c), bromide (1d, 2d, 3d, 4d) or iodine (1e, 2e, 3e, 4e) at the
C-3 position further enhanced cytotoxicity (Table I). 
All of these compounds failed to stimulate Raw 264.7 cells
to produce detectable amounts of NO, but did inhibit NO
production by LPS-activated Raw 264.7 cells to various extents
(Table I). 1-Trichloroacetyl-2-methoxyazulene (2a) and 
1-trichloroacetyl-2-ethoxyazulene (4a), with low cytotoxic
activity (CC50 >400 and >500, respectively), inhibited NO
production to the greatest extent (IC50=22.7 and 21.2 ÌM,
respectively) (Figure 2), producing the highest selectivity index
(SI) of >24.7 and >28.7, respectively (Table I). 
Effect on iNOS expression. We next investigated whether the
inhibition of NO production by (2a) and (4a) was due to the
reduced expression of iNOS mRNA expression. RT-PCR
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Figure 3. Effect of trihaloacetylazulenes on LPS-stimulated iNOS mRNA expression. Raw 264.7 cells were incubated for 24 hours with (A) 1-trichloroacetyl-
2-methoxyazulene (2a) or (B) 1-trichloroacetyl-2-ethoxyazulene (4a) in the presence of 100 ng/mL LPS. RNA was then isolated, and the RT-PCR product
was applied to agarose gel electrophoresis and quantified by NIH image. The expression of iNOS mRNA was expressed as its ratio to that of ‚-actin mRNA.
Each value represents the mean from 3 independent experiments; (+) and (–) represent the presence or absence of 100 ng/mL LPS. *p<0.05.
analysis showed that this was in fact the case. Compounds
2a and 4a inhibited iNOS mRNA expression (IC50=17.0
and 18.8 ÌM, respectively), as efficiently as they did NO
production (Figure 3). However, western blot analysis
showed that these compounds reduced the intracellular
concentration of iNOS protein only at higher concentrations
(IC50≥90.8 and 82.4 ÌM, respectively) (Figure 4). 
Radical production and scavenging activity. ESR spectroscopy
showed that compounds (2a and 4a) did not produce any
detectable amounts of radical at pH 13.5 (Table II). These
compounds slightly scavenge O2
– at higher concentration
(>1.2 mM), whereas they did not affect the radical intensity of
NO or DPPH at a wide range of concentrations (0.2-12 mM)
(Table II). 
Discussion
The present study demonstrates for the first time that ten
trichloroacetylazulenes (2a-e, 4a-e) generally showed higher
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Figure 4. Effect of trihaloacetylazulenes on the intracellular concentration of iNOS proteins in Raw 264.7 cells. Raw 264.7 cells were incubated for 24
hours with the indicated concentrations of 1-trichloroacetyl-2-methoxyazulene (2a) or 1-trichloroacetyl-2-ethoxyazulene (4a) in the presence of 100 ng/mL
LPS. Cell lysate was applied to SDS-PAGE and iNOS protein was quantified by western blot analysis, followed by NIH imaging. The intracellular iNOS
protein was expressed as its ratio to that of actin protein. The iNOS protein concentration without LPS was below the detection limit. Each value
represents the mean from 3 independent experiments; (+) and (–) represent the presence or absence of 100 ng/mL LPS. *p<0.05.
cytotoxicity against Raw264.7 cells as compared with their
corresponding trifluoroacetylazulenes (1a-e, 3a-e), confirming
the result from our previous study (21). We recently reported
that the former compounds showed higher cytotoxicity
against human tumor cell lines than did the latter (23).
Among these twenty compounds, compounds 2a and 4a most
efficiently inhibited NO production by LPS-activated Raw
264.7 cells, with the highest selectivity index (Table I). The
NO concentration in the medium is influenced by both the
intracellular concentration and activity of iNOS protein and
the quenching of NO radicals. NO radicals interact with
superoxide anions (O2
–) (36). We found that compounds 2a
and 4a did not scavenge the NO radical (produced from
NOC-7, an NO donor), even at 4 mM, a two hundred-fold
higher concentration that induced 50% reduction in the NO
production by LPS-stimulated Raw 264.7 cells. Furthermore,
none of these compounds increased O2
– but rather
scavenged it, which is known to interfere with the NO
molecule. These data suggest that inhibition of NO
production by compounds 2a and 4a is not due to the NO
scavenging activity. We also found that compounds 2a and
4a inhibited iNOS mRNA expression at the same
concentration at which it inhibited NO production. However,
these compounds reduced the intracellular concentration of
iNOS protein to a lesser extent. These data suggest that
these compounds may inactivate the iNOS protein.
Our recent studies demonstrated that trihaloacetylazulene
derivatives show diverse biological activity. Although
1-trichloroacetyl-3-bromo-2-methoxyazulene (2d) and
1-trichloroacetyl-3-chloro-2-ethoxyazulene (4c) showed the
highest cytotoxicity and tumor specificity (TS of >3.5 and
>2.5, respectively) (23), they inhibited NO production by
activated macrophages very weakly (SI=5.4 and 4.9,
respectively) (Table I). Although compounds (2a and 4a)
inhibited NO production by activated macrophages very
potently (SI of >24.7 and >28.7, respectively) (Table I), they
showed very weak tumor-specific cytotoxicity (TS of >1.7
and >2.0, respectively) (23). These data indicate that these
biological activities of trihaloacetylazulenes do not overlap
with each other. Further studies are required to test the
possible anti-inflammatory action of trihaloacetylazulenes. 
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